Growth Metrics

Item 9 Labs (INLB) Cash from Financing Activities (2018 - 2023)

Item 9 Labs' Cash from Financing Activities history spans 12 years, with the latest figure at -$5013.0 for Q2 2023.

  • For Q2 2023, Cash from Financing Activities fell 100.39% year-over-year to -$5013.0; the TTM value through Jun 2023 reached $4.4 million, up 13.29%, while the annual FY2022 figure was $6.0 million, 46.39% down from the prior year.
  • Cash from Financing Activities reached -$5013.0 in Q2 2023 per INLB's latest filing, down from $1.3 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $6.4 million in Q1 2021 to a low of -$361332.0 in Q3 2020.
  • Average Cash from Financing Activities over 5 years is $1.5 million, with a median of $1.3 million recorded in 2022.
  • Peak YoY movement for Cash from Financing Activities: plummeted 115.87% in 2020, then soared 1527.42% in 2022.
  • A 5-year view of Cash from Financing Activities shows it stood at $469000.0 in 2019, then surged by 891.96% to $4.7 million in 2020, then crashed by 91.12% to $413100.0 in 2021, then surged by 208.14% to $1.3 million in 2022, then crashed by 100.39% to -$5013.0 in 2023.
  • Per Business Quant, the three most recent readings for INLB's Cash from Financing Activities are -$5013.0 (Q2 2023), $1.3 million (Q3 2022), and $1.3 million (Q2 2022).